Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

Journal:

The New England Journal of Medicine

Published:

2026-03-07

DOI:

10.1056/nejmoa2516150

Affiliations:

27

Authors:

25

Go to article

Institutions	Authors	Share
Genentech, Inc., United States of America (USA)	3.000000	0.12
Roche, Switzerland	2.000000	0.08
Northwell Health, United States of America (USA)	1.000000	0.04
Centro Médico Nacional La Raza, Mexico	1.000000	0.04
Hoffmann-La Roche Ltd., Canada	1.000000	0.04
Centro de Investigación y Tratamiento Reumatológico SC, Mexico	1.000000	0.04
Clínica San Juan Bautista, Peru	1.000000	0.04
Netcare uMhlanga Medical Centre, South Africa	1.000000	0.04
Poznan University of Medical Sciences (PUMS), Poland	1.000000	0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.04
Autonomous University of Coahuila (UAdeC), Mexico	1.000000	0.04
Middlemore Hospital, New Zealand	1.000000	0.04
Clínica San Juan de Dios Arequipa, Peru	1.000000	0.04
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.04
Centro Mineiro de Pesquisa (CMIP), Brazil	1.000000	0.04
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.04
Instituto de Ginecología y Reproducción, Peru	1.000000	0.04
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.04
Winelands Medical Research Centre, South Africa	1.000000	0.04
Catholic University of the Sacred Heart (UCSC), Italy	0.500000	0.02
NIHR Leeds Biomedical Research Centre, United Kingdom (UK)	0.500000	0.02
University of Leeds, United Kingdom (UK)	0.500000	0.02
Agostino Gemelli University Polyclinic, Italy	0.500000	0.02
Federal University of Bahia (UFBA), Brazil	0.333333	0.01
Bahia School of Medicine and Public Health (BAHIANA), Brazil	0.333333	0.01
Clínica Ser da Bahia - Reumatologia, Brazil	0.333333	0.01

Interested in Clinical Sciences?